CompletedPhase 4NCT01797861
Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy
Studying Central serous chorioretinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radboud University Medical Center
- Principal Investigator
- Camiel JF Boon, MD PhD FEBOLeiden University Medical Center & Radboud University Nijmegen Medical Center
- Intervention
- Half-dose photodynamic therapy (PDT)(procedure)
- Enrollment
- 140 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2017
Study locations (5)
- Creteil University Eye Clinic, Paris, France
- Cologne University Eye Clinic, Cologne, Germany
- Leiden University Medical Center, Leiden, Netherlands
- Radboud University Nijmegen Medical Centre, Institute of Ophthalmology, Nijmegen, Netherlands
- Oxford University Eye Hospital, John Radcliffe Hospital, Oxford, United Kingdom
Collaborators
University of Cologne · University of Oxford · Leiden University Medical Center · University Hospital, Paris
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01797861 on ClinicalTrials.govOther trials for Central serous chorioretinopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06527326the Study of the Association Between the Gut Microbiota and Central Serous ChorioretinopathySecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT06346405Central Serous Chorioretinopathy and Micropulse Laser TreatmentFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNANCT05570591Subthreshold Nanosecond Laser for Non-resolving Central Serous ChorioretinopathyNova Eye Medical Pty Ltd.
- RECRUITINGNCT05589974Choroidal Blood Flow in Acute and Chronic Central Serous ChorioretinopathyHelse Stavanger HF